COVID-19 may be the most disruptive force any of us will ever experience. The last thing plan members needed was angst when it came to their prescriptions. We used predictive analytics to avoid disruptions — particularly within our pharmaceutical supply chain:
Adapted our supply chain to account for early COVID-19 spikes in primary supply chain locations like Northern Italy, India and China.
Secured supply and implemented quantity limits on drugs like hydroxychloroquine and albuterol — when there were some early suggestions that they had a role to play in COVID-19 — to prevent unnecessary stockpiling. We did not want to trade one public health crisis for another.